Irritable Bowel Syndrome (IBS), and other persistent visceral pain syndromes such as interstitial cystitis/painful bladder syndrome present a heterogeneous group of patients with often overlapping symptoms. We hypothesize that biologically determined subsets of IBS patients are composed of distinct clusters of biological and behavioral endophenotypes. Some of the involved endophenotypes show sex-related differences, biasing most of these syndromes towards female predominance. Our SCOR research during the past funding period has enabled us to generate a group of testable candidate endophenotypes, many with sex differences, that relate to important clinical characteristics in functional GI disorders. We propose to test the general hypothesis that distinct subgroups of patients can be identified in a population meeting IBS symptom criteria using a phenomics approach in three Aims.
In Aim A, we will prospectively perform comprehensive endophenotyping of 120 IBS patients (60 women). Multimodal brain imaging and psychophysiological techniqes, together with behavioral measures will be used to identify central endophenotypes related to stress hyperresponsiveness, pain sensitivity and cognitive modulation. These endophenotypes will be combined in a comprehensive data base with neuroendocrine (including HPA axis parameters studied in Project 1), and peripheral endophenotypes (including visceral adipose tissue [VAT] and adipokines, studied in Project 2).
In Aim B, we will use interventional phenotyping using a corticotropin releasing factor type 1 receptor (CRF-R1) antagonist in 60 female IBS patients to test the hypothesis that a subgroup of IBS patients with an upregulated CRF/CRF-R1 signaling system can be identified by their responsiveness to a selective CRF-R1 antagonist, while other subgroups show minimal or no response.
In Aim C we will apply advanced mathematical modeling techniques to identify patient subgroups from endophenotypes identified in Aims A and B to test the hypotheses that subgroups of IBS patients can be identified based on unique clusters of endophenotypes, that some of these endophenotypes are responsible for the greater female prevalence of IBS and related syndromes.

Public Health Relevance

Irritable bowel syndrome is a common disorder of considerable human and financial impact, with inadequate treatment options. Identification of objective and biologically based subgroups of irritable bowel syndrome patients is essential to improving the development of targeted, effective treatments for this disorder.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Specialized Center (P50)
Project #
5P50DK064539-12
Application #
8539774
Study Section
Special Emphasis Panel (ZRG1-EMNR-Q)
Project Start
Project End
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
12
Fiscal Year
2013
Total Cost
$208,895
Indirect Cost
$73,518
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Mulak, Agata; Larauche, Muriel; Biraud, Mandy et al. (2015) Selective agonists of somatostatin receptor subtype 1 or 2 injected peripherally induce antihyperalgesic effect in two models of visceral hypersensitivity in mice. Peptides 63:71-80
Kilpatrick, Lisa A; Coveleskie, Kristen; Connolly, Lynn et al. (2014) Influence of sucrose ingestion on brainstem and hypothalamic intrinsic oscillations in lean and obese women. Gastroenterology 146:1212-21
Chang, Megan C; Shapiro, David; Joshi, Aditi et al. (2014) Stress reactivity in traditional Chinese medicine-based subgroups of patients with irritable bowel syndrome. J Altern Complement Med 20:276-83
Su, A M; Shih, W; Presson, A P et al. (2014) Characterization of symptoms in irritable bowel syndrome with mixed bowel habit pattern. Neurogastroenterol Motil 26:36-45
Hanna-Mitchell, Ann T; Wolf-Johnston, Amanda; Roppolo, James R et al. (2014) Corticotropin-releasing factor family peptide signaling in feline bladder urothelial cells. J Endocrinol 222:113-21
Mulak, Agata; Taché, Yvette; Larauche, Muriel (2014) Sex hormones in the modulation of irritable bowel syndrome. World J Gastroenterol 20:2433-48
Hong, Jui-Yang; Labus, Jennifer S; Jiang, Zhiguo et al. (2014) Regional neuroplastic brain changes in patients with chronic inflammatory and non-inflammatory visceral pain. PLoS One 9:e84564
Cohen, Erica; Bolus, Roger; Khanna, Dinesh et al. (2014) GERD symptoms in the general population: prevalence and severity versus care-seeking patients. Dig Dis Sci 59:2488-96
Labus, Jennifer S; Dinov, Ivo D; Jiang, Zhiguo et al. (2014) Irritable bowel syndrome in female patients is associated with alterations in structural brain networks. Pain 155:137-49
Gupta, Arpana; Kilpatrick, Lisa; Labus, Jennifer et al. (2014) Early adverse life events and resting state neural networks in patients with chronic abdominal pain: evidence for sex differences. Psychosom Med 76:404-12

Showing the most recent 10 out of 134 publications